Gallery

Roche Schizophrenia, MS Drugs Move to Final Stages of Clinical Testing – Bloomberg

This is a very positive development, if it holds up: A new medicine for schizophrenia that helps the negative symptoms…often the toughest to deal with in recovery.

Schizophrenia Symptoms

RG1678, a so-called glycine reuptake inhibitor, was effective in reducing the “negative symptoms” of schizophrenia, Roche said Dec. 6. These include a loss of motivation and interest in social activities, isolation and difficulty finding pleasure in everyday life, the company said. Current treatments for the disease mostly address the positive symptoms for the disease, which include hallucinations and delusions, Roche said.

The mental disorder affects about 24 million people worldwide and is usually diagnosed in people aged between 15 and 35 years old, Roche said.

via Roche Schizophrenia, MS Drugs Move to Final Stages of Clinical Testing – Bloomberg.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s